<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="./10_1101_2020_03_18_997585v1/results/search/disease/results.xml">
  <result pre="for the current COVID-19 pandemic. Based on our analysis of" exact="hepatitis" post="C virus and coronavirus replication, and the molecular structures"/>
  <result pre="form of Sofosbuvir (a key component of the FDA approved" exact="hepatitis" post="C drug EPCLUSA), is incorporated by SARS-CoV-2 RdRp, and"/>
  <result pre="Tenofovir alafenamide (TAF, an FDA approved drug for HIV and" exact="hepatitis" post="B) for evaluation as inhibitors of SARS-CoV-2 RdRp. We"/>
  <result pre="viruses, sharing properties with other single-stranded RNA viruses such as" exact="hepatitis" post="C virus (HCV), West Nile virus, Marburg virus, HIV"/>
  <result pre="of anti-viral agents. 6– 9 Based on our analysis of" exact="hepatitis" post="C virus and coronavirus replication, and the molecular structures"/>
  <result pre="c), which is an FDA approved drug for HIV and" exact="hepatitis" post="B virus (HBV) infection, for evaluation as a SARS-CoV-2"/>
  <result pre="Investigating and Research Team. A novel coronavirus from patients with" exact="pneumonia" post="in China, 2019. N Eng J Med 382, 727–"/>
  <result pre="Lloyd, A. R. &amp;amp;; Bull, R. A. Inhibitors of the" exact="hepatitis" post="C virus polymerase; mode of action and resistance. Viruses"/>
  <result pre="doi.org/10.1101/2020.03.12.989186 ( 2020). 11. ↵ Subissi, L. et al. One" exact="severe acute respiratory syndrome" post="coronavirus protein complex integrates processive RNA polymerase and exonuclease"/>
  <result pre="from scientific discovery to clinical applications: Tenofovir disproxil fumarate for" exact="hepatitis" post="B. J Clin Translat Hepatol 1, 33– 38 ("/>
 </snippets>
</snippetsTree>
